EN
instrument_fundamentals
| date | Close | change | Change (%) | instr__open | High | Low |
|---|
instr__news
AstraZeneca Buys Belgian EsoBiotec for Up to $1 Billion to Boost Cell-Therapy Portfolio | Morningstar
AstraZeneca to buy EsoBiotec for up to US$1 billion - The Business Times
EsoBiotec to Be Acquired by AstraZeneca to Advance Cell Therapy Ambition
AstraZeneca To Buy Belgium's Cell Therapy Firm EsoBiotec In Up To $1 Bln Deal
Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial results
Luveltamab Tazevibulin Produces Responses in Platinum-Resistant Ovarian Cancer With Low/Medium FRα Expression
Updated MIRASOL Data Support Mirvetuximab Soravtansine as SOC for FRα+ Platinum-Resistant Ovarian Cancer
Nicholas Company Inc. Raises Stock Position in AstraZeneca PLC (NASDAQ:AZN)
Clearstead Trust LLC Has $289,000 Holdings in AstraZeneca PLC (NASDAQ:AZN)
Zevin Asset Management LLC Grows Position in AstraZeneca PLC (NASDAQ:AZN)
AGF Management Ltd. Cuts Stock Position in AstraZeneca PLC (NASDAQ:AZN)
Parnassus Investments LLC Boosts Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca (LON:AZN) Stock Crosses Above 200 Day Moving Average - What's Next?
AstraZeneca's Portfolio and Pipeline Support Solid Long-Term Growth | Morningstar
AstraZeneca and Erin Andrews team up to inspire fans to Get Body Checked Against Cancer
AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Avantax Advisory Services Inc.
Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials
Cellectis reports Q4 EPS (64c) vs (17c) last year | Markets Insider
Sage Mountain Advisors LLC Decreases Stock Position in AstraZeneca PLC (NASDAQ:AZN)
Tolerance and effectiveness of inhaled antibiotics at standard or low doses in COPD patients with chronic Pseudomonas aeruginosa bronchial infection
First insights and future research perspectives from the sarcoidosis registry at the Medical University of Vienna
Delaware High Court Weighs Reviving AstraZeneca Shareholder Suit
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD Makes New Investment in AstraZeneca PLC (NASDAQ:AZN)
Natural Investments LLC Purchases New Position in AstraZeneca PLC (NASDAQ:AZN)
Davis R M Inc. Invests $268,000 in AstraZeneca PLC (NASDAQ:AZN)
Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know - March 12, 2025 - Zacks.com
Lynparza and Breast Cancer: Study Finds Reduced Recurrence Risk in HR-Positive Patients
15,663 Shares in AstraZeneca PLC (NASDAQ:AZN) Purchased by Sowell Financial Services LLC
AstraZeneca PLC (NASDAQ:AZN) Shares Sold by PNC Financial Services Group Inc.
Victory Capital Management Inc. Boosts Stock Position in AstraZeneca PLC (NASDAQ:AZN)
Arvinas, Pfizer Report Positive Topline Data From Phase 3 VERITAC-2 Study
Astrazeneca divulges new antibody-drug conjugates | BioWorld
IONS/AZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe - March 11, 2025 - Zacks.com
A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer
Sound View Wealth Advisors Group LLC Raises Position in AstraZeneca PLC (NASDAQ:AZN)
6,500 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by American Assets Inc.
Morton Community Bank Buys 2,405 Shares of AstraZeneca PLC (NASDAQ:AZN)
Ionis and AstraZeneca's WAINZUA gets EU approval for ATTRv-PN treatment | Markets Insider
AstraZeneca PLC (NASDAQ:AZN) Position Boosted by Banco Santander S.A.
UBS Keeps Their Buy Rating on AstraZeneca (AZN) | Markets Insider
Argentarii LLC Purchases New Shares in AstraZeneca PLC (NASDAQ:AZN)
HM Payson & Co. Decreases Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)
Ionis Pharma Reports Approval Of WAINZUA In The EU - Quick Facts
AstraZeneca Share Price Today, AstraZeneca Stock Price Live NSE/BSE, Share Price Insights
Scientists link new gene to high Parkinson's disease risk
MORPHEUS-Liver provides a way forward in expanding the immunotherapy options for hepatocellular carcinoma
HER2+ Gastric Cancer Market to Witness Upsurge in Growth During the Forecast Period (2024-2034), Examine DelveInsight | ABNewswire
Dorsey & Whitney Trust CO LLC Buys 189 Shares of AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca PLC (NASDAQ:AZN) Shares Bought by Sound View Wealth Advisors Group LLC
American Assets Inc. Buys Shares of 6,500 AstraZeneca PLC (NASDAQ:AZN)
E Fund Management Co. Ltd. Purchases 1,488 Shares of AstraZeneca PLC (NASDAQ:AZN)
Axis Wealth Partners LLC Invests $269,000 in AstraZeneca PLC (NASDAQ:AZN)
Charles Schwab Investment Management Inc. Reduces Position in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Charles Schwab Investment Management Inc.
Naviter Wealth LLC Sells 1,376 Shares of AstraZeneca PLC (NASDAQ:AZN)
Vestmark Advisory Solutions Inc. Grows Holdings in AstraZeneca PLC (NASDAQ:AZN)
Jones Financial Companies Lllp Has $1.06 Million Position in AstraZeneca PLC (NASDAQ:AZN)
Raymond James Financial Inc. Invests $158.02 Million in AstraZeneca PLC (NASDAQ:AZN)
Steward Partners Investment Advisory LLC Cuts Stake in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca PLC's (LON:AZN) Intrinsic Value Is Potentially 81% Above Its Share Price
Study links ITSN1 gene variants to increased Parkinson's disease risk
AstraZeneca receives CDSCO approval for Durvalumab in treating limited-stage small cell Lung Cancer
Reduced reproductive potential in young healthy women with hereditary breast and/or ovarian cancer syndrome
Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancer
AstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Cullen Frost Bankers Inc.
AstraZeneca PLC (NASDAQ:AZN) Shares Bought by Assetmark Inc.
AstraZeneca (LON:AZN) Receives "Buy" Rating from Shore Capital
AZN : Imfinzi Improves Event-Free Survival In Early-Stage Gastric & GEJ Cancers In Phase III Trial
Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trial
Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial
Pinnacle Wealth Planning Services Inc. Sells 260 Shares of AstraZeneca PLC (NASDAQ:AZN)
Verdence Capital Advisors LLC Has $2.13 Million Stock Position in AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca gets nod to import, sell hyperkalaemia treatment drug in India
AstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Up 23.1% in February
M&T Bank Corp Sells 7,931 Shares of AstraZeneca PLC (NASDAQ:AZN)
24,168 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by Exencial Wealth Advisors LLC
Astrazeneca (AZN) Stock Moves -0.63%: What You Should Know - March 6, 2025 - Zacks.com
Meta-analysis of genome-wide associations and polygenic risk prediction for atrial fibrillation in more than 180,000 cases
AstraZeneca to bring innovative medicines faster to India, says MD Panchal
PM calls on AstraZeneca to transfer vaccine technology to Việt Nam
Compugen Ltd. (NASDAQ:CGEN) Q4 2024 Earnings Call Transcript
LGT Group Foundation Invests $233,000 in AstraZeneca PLC (NASDAQ:AZN)
Bank of New York Mellon Corp Trims Stock Position in AstraZeneca PLC (NASDAQ:AZN)
Rare Kidney Diseases Market Growth & Trends: Impact of Next-Generation Sequencing and Precision Medicine
Real-World outcomes with sacituzumab govitecan among breast cancer patients with central nervous system metastases
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial
AstraZeneca & GSK Unite to Cut Healthcare Emissions in China
Norden Group LLC Increases Holdings in AstraZeneca PLC (NASDAQ:AZN)
SVB Wealth LLC Invests $784,000 in AstraZeneca PLC (NASDAQ:AZN)
US Bancorp DE Boosts Stock Position in AstraZeneca PLC (NASDAQ:AZN)
Latest news
Oil Market Today: Oil prices surge amid rising tensions in the Red Sea
Bank of Japan to discuss economic risks associated with the Trump trade war
Dow Jones futures decline following a Nasdaq rally led by Tesla and Nvidia
